Found 30 matching trials
Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis PHASE2 Study B7451006 is a Phase 2b POC study which is planned to assess four PF 0...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants PHASE1 This is a Phase 1, randomized, 2 way crossover, single dose, open label stu...
Show More Location
Pfizer Clinical Research Unit
Learn More & Join Trial
A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India PHASE3 The purpose of this clinical trial is to learn about the safety and how wel...
Show More Location
Nirmal Hospital Pvt Ltd.
Learn More & Join Trial
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome PHASE2 This is a single-center, open-label, basket phase 2b trial that will enroll...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants PHASE1 This is a Phase 1, open-label, multiple dose, single fixed-sequence, 2-peri...
Show More Location
Research Centers of America ( Hollywood )
Learn More & Join Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis PHASE3 This is a randomized, double blind, placebo controlled, parallel group, Pha...
Show More Location
Clinical Research Center of Alabama, LLC
Learn More & Join Trial
First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects PHASE1 This single- and multiple-ascending dose study is the first evaluation of P...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis PHASE2 Study B7451005 is a Phase 2 study which will assess the efficacy and safety...
Show More Location
Total Skin and Beauty Dermatology Center, PC
Learn More & Join Trial
Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants PHASE1 This is a Phase 1, randomized, 2 way crossover, multiple dose, open label s...
Show More Location
Pfizer Clinical Research Unit
Learn More & Join Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis PHASE3 B7451012 is a Phase 3 study to evaluate PF-04965842 in patients aged 12 yea...
Show More Location
Clinical Research Center of Alabama, LLC
Learn More & Join Trial